The mechanism whereby the placental cells of a human immunodeficiency virus (HIV)-1-infected mother protect the fetus from HIV-1 infection is unclear. Interferons (IFNs) inhibit the replication of viruses by acting at various stages of the life cycle and may play a role in protecting against vertical transmission of HIV-1. In addition the b-chemokines RANTES (regulated on activation T cell expressed and secreted), macrophage inflammatory protein-1-a (MIP-1a), and MIP-1b can block HIV-1 entry into cells by preventing the binding of the macrophage-trophic HIV-1 strains to the coreceptor CCR5. In this study the production of IFNs and b-chemokines by placental trophoblasts of HIV-1-infected women who were HIV-1 non-transmitters was examined. Methods: Placental trophoblastic cells were isolated from 29 HIV-1-infected and 10 control subjects. Supernatants of trophoblast cultures were tested for the production of IFNs and b-chemokines by enzyme linked immunosorbent assay (ELISA). Additionally, HIV-1-gag and IFN-b transcripts were determined by a semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) assay. Results: All placental trophoblasts of HIV-1-infected women contained HIV-1-gag transcripts. There were no statistical differences in the median constitutive levels of IFN-a and IFN-g produced by trophoblasts of HIV-1-infected and control subjects. In contrast, trophoblasts of HIV-1-infected women constitutively produced significantly higher levels of IFN-b protein than trophoblasts of control subjects. Furthermore, the median levels of b-chemokines produced by trophoblasts of HIV-infected and control women were similar. Conclusions: Since there was no correlation between the placental HIV load and the production of interferons or b-chemokines, the role of trophoblast-derived IFNs and b-chemokines in protecting the fetus from infection with HIV-1 is not clear.
The mechanism by which HIV-1 infection is transmitted from a mother to her infant is unclear but may be related to a number of risk factors, including preterm labor, the interval between membrane rupture and delivery, and whether the mother breastfeeds or is infected with a sexuallytransmitted disease during pregnancy 1 . At the cellular level vertical transmission of HIV-1 may occur as a result of an infected maternal cell crossing from the maternal circulation into the fetal circulation or by the direct transfer of the virus from a maternal cell to a fetal cell 2 . For example, it has been suggested that maternal macrophagetrophic virus may serve as a vehicle to infect the fetus via infection of placental macrophages 3, 4 . Placental macrophages become infected with HIV-1 through the CD4 receptor 5, 6 and the CCR5 coreceptor 7 . However, the susceptibility of placental trophoblasts to infection with HIV-1 is controversial: both successful 2, 4, 8 and unsuccessful 9 ,10 infections have been reported. In support of the former, we 11 and others 2, 4, 12, 13 have found HIV-1 provirus in macrophages and trophoblasts and HIV-1-gag transcripts in the placental trophoblasts from women infected with HIV-1 14 . Nonetheless, the replication rate of HIV-1 in trophoblasts is low 15, 16 and may not permit dissemination of the infection to other placental cells.
Immunological factors increasing the risk of maternal-to-fetal HIV-1 transmission include maternal immunosuppression 17 and inflammation of the placental membranes, mainly mediated by cytokines 18, 19 . Placental macrophages and trophoblasts constitutively secrete a variety of cytokines, including granulocyte-macrophage colony stimulating factor, colony-stimulating factor, interleukin (IL)-1b, IL-6, tumor necrosis factor-a (TNF-a), interferons, and transforming growth factor 20 . That some cytokines can up-regulate HIV-1 expression in T cells 21 and in a promonocytic cell line 22 has been demonstrated and may provide a mechanism through which fetal and maternal cells latently infected with HIV-1 become activated and release productive virus. Thus, it is tempting to speculate that the presence of inflammatory cytokines in the placental microenvironment plays a regulatory role in the expression of HIV-1. Even so, the presence of HIV-1-infected cells in the placenta and abnormal maternal immunologic characteristics do not always lead to vertical transmission 14 . While some workers believe that the suboptimal permissiveness of trophoblasts for HIV-1 replication may involve a restriction at the level of HIV-1 integration 13 , others have speculated that factors influencing viral gene transcription and translation may be responsible 23, 24 . Throughout pregnancy interferons (IFNs) can be detected in the maternal and fetal blood circulations in response to intrauterine infection with herpes simplex virus 25 , albeit sporadically and at low concentration 26 . Monocyte-macrophage tropic HIV-1 isolates are non-syncytium inducing and are the predominant isolates transmitted from mother to fetus [27] [28] [29] . Placental macrophages express the CD4 receptor and the CCR3 and CCR5 chemokine coreceptors 7 that facilitate the entry of HIV-1 into the cell. Placental trophoblasts can be infected with HIV-1 even though they may express chemokine receptors 30 , and not the CD4 receptor 8, 12, [30] [31] [32] . Chemokines on the other hand may prevent infection of maternal and fetal cells in the placenta by preventing the binding of HIV-1 to the chemokine receptors 33, 34 on the surface of the susceptible cells. In this study the hypothesis that placental HIV-1 load, as measured by the level of HIV-1-gag transcripts, is inversely correlated with the levels of IFNs and chemokines produced by the trophoblasts was tested.
SUBJECTS AND METHODS

Study population
Thirty-nine women, of whom 29 were HIV-1-infected and ten were uninfected and healthy, agreed to particpate in this study, which was approved by the Institutional Research Board of the hospitals affiliated with the Harris County Hospital District in Houston, Texas. According to the census of the Texas Department of Health, the racial and ethnic distribution of parturient women in Harris County at the time of this study was 86% African-American, 5% Hispanic, and 9% other races. Among the 29 HIV-1-infected gravidas from whom term placentas were obtained at delivery, six were symptomatic for HIV-1 disease throughout pregnancy. Five of the symptomatic and 18 of the asymptomatic HIV-1-infected women received zidovudine (ZDV), either intrapartum or throughout pregnancy, or both (Table 1) . CD4 T-cell counts were available for 22 of the HIV-1-infected women. Blood samples from 25 infants, including a set of twins, born to HIV-1-infected women were obtained at birth, 1 month, 6 months, and 12 months of age. The blood was assayed for the presence of HIV-1 infection by the co-culture method and/or for HIV-1 proviral DNA by the polymerase chain reaction (PCR). Enumeration of peripheral CD4+ T-cell counts of these infants was performed at birth. Five infants were lost to follow-up.
Control placentas were collected from normal term deliveries performed by the same obstetrician who delivered the HIV patients. They were selected based on term gestation, with no medical complications of pregnancy or delivery. Delivery was vaginal or by scheduled repeat Cesarean section. The maternal ages of the control subjects and the HIV patients were similar.
Isolation of placental trophoblastic cells
Trophoblastic cells were isolated from human term placentas of 36-40 weeks' gestation.
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Immediately after delivery rigorous isolation procedures 14, [35] [36] [37] were employed to ensure the purity of the trophoblast preparations. Cell morphology and the production of human chorionic gonadotropin were determined in trophoblastic cell preparations using immunocytochemical staining as previously reported 14 .
Cytospin preparations of the final trophoblastic cell fractions were stained with Wright-Giemsa medium. The trophoblast preparations consisted of a mixture of syncytiotrophoblasts and cytotrophoblasts, with < 3% leukocyte contamination.
Production of interferons and b-chemokines by trophoblasts
Two ml aliquots of trophoblasts at a concentration of 2 x 10 6 cells/ml in RPMI-1640 medium supplemented with L-glutamine, 10% human AB serum and antibiotics (200 U/ml penicillin and 200 mg/ml streptomycin) were placed in 12 mm´75 mm tubes (Sigma Chemical Co., St. Louis, MO) and incubated at 37°C in a humidified atmosphere with 5% CO2 for up to 48 h. At 12 h and 24 h the culture tubes were centrifuged at 450g for 10 min; the culture supernatants were harvested and stored frozen at -20°C until assayed for IFNs and b-chemokines. The levels of IFN-a, IFN-g, macrophage inflammatory protein-1-a (MIP-1a), MIP-1b, and RANTES (regulated on activation T cell expressed and secreted) were determined in supernatants of trophoblastic cell cultures using QuantikineÔ ELISA kits (R & D Systems, Minneapolis, MN). The level of IFN-b in supernatants of trophoblastic cell cultures was determined using the HuIFN-b1 ELISA kit (Toray-Fuji Bionics Inc., Tokyo, Japan). All measurements reported are the means of duplicate sampling.
Reverse transcription of RNA into cDNA
Single-stranded cDNA in a final volume of 20 ml was prepared by reverse transcription using (RT) the GeneAmp RT-PCR kit (Applied Biosystems, Foster City, CA). Briefly, after denaturation of 1 mg freshly prepared RNA at 68°C for 10 min, a reaction mixture containing 2.5 mM random hexamers, 1 mM dNTP, 5 mM MgCl2, 20 U RNase inhibitor, and 50 U murine leukemia virus (MuLV) reverse transcriptase was added to the sample tube. The reaction was then allowed to proceed at 42°C for 60 min, followed by additional heating at 95°C for 5 min to inactivate the enzyme. The resultant cDNA was either used immediately or stored at -20°C.
Detection of HIV-1 RNA transcripts by RT-PCR
The cDNA synthesized from 1 mg total RNA isolated from trophoblastic cells was used for PCR amplification of HIV-1-gag sequences. To minimize misprimed DNA amplification following cDNA synthesis, the Hot Start PCR method was used 38 . After AmpliWaxÔ (Applied Biosystems) was added to tubes containing the cDNA, the tubes were heated at 80°C for 5 min, and then cooled down to 25°C for 5 min. The PCR master mixture (0.2 mM primers SK38 and SK39, 0.2 mM dNTP, 2 mM MgCl2, PCR Buffer II, and 2.5 U AmpliTaq DNA polymerase) was prepared using RT-PCR core reagents supplied by Applied Biosystems, and aliquoted to each tube. The sequences for the HIV-1-gag specific primers SK38 and SK39 (Applied Biosystems) are 5¢ATAATCC ACCTATCCCAGTAGGAGAAAT3¢ and 5¢ TT TGGTCCTTGTCTTATGTCCAGAATGC3¢, respectively. After heating at 94°C for 5 min, the PCR was carried out for 35 cycles of 30 s at 94°C, 30 s at 55°C and 30 s at 72°C and immediately followed by a final extension at 72°C for 10 min using a thermal cycler (Model 9600; Perkin-Elmer Cetus, Norwalk, CT).
Two-fold serial dilutions, ranging from 5000 down to 156 copies, of HIV-1 positive control DNA and HIV-1 negative control DNA (Applied Biosystems) were also amplified by the PCR. The specificity of the HIV-1-gag sequence was verified by vacuum blotting the PCR product onto a nylon membrane (GeneScreen Plus; DuPont, Boston, MA), followed by hybridization with 32 P-labeled SK19 oligonucleotide (Applied Biosystems). The Southern blot of the HIV-1-gag PCR products was visualized using a PhosphoImager (Molecular Dynamics, Sunnyvale, CA). Based on the signal intensity of the band, each sample was arbitrarily scored as having 'low' or 'high' copies of HIV-1-gag transcripts if the pixal value of the sample band was less than or greater than the number of HIV-1-gag transcripts in the highest dilution for the positive standard. Hence, samples with < 156 copies were scored as 'low' and samples with > 156 copies were scored as 'high'. 
Statistical analysis
The nonparametric Mann-Whitney test was used to determine differences in the production of IFNs and b-chemokines and the level of IFN-b transcription by placental trophoblasts of HIV-1-infected and control women. The software package PRISMÔ (GraphPad Software, Inc., San Diego, CA) was used to perform the statistical analyses.
RESULTS
Characteristics of study subjects
Twenty-five infants born to HIV-1-infected mothers had clinical follow-up visits for three years at the Pediatric AIDS Clinical Trials Unit in Houston and showed no evidence of HIV-1 infection ( Table 1 ). The HIV-1-gag sequence was present in trophoblasts of all HIV-1-infected women. Based on the semi-quantitative RT-PCR, 12 of the 29 placental trophoblast preparations from HIV-1 infected women had < 156 copies of HIV-1-gag transcripts (Table 1) .
Constitutive levels of IFN-a, IFN-b, and IFN-g produced by placental trophoblasts in culture Constitutive levels of IFN-a, IFN-b, and IFN-g were measured in culture supernatants of trophoblasts isolated from 29 HIV-1-infected and 9 control women. The median level of IFN-b constitutively produced by trophoblasts of HIV-1-infected women over a 24-h period was significantly higher than that of control women (Figure 1) . The median constitutive levels of IFN-b for HIV-1-infected compared with control women were 3.5 pg/ml versus 3.1 pg/ml (p = 0.0465) at 12 h and 3.7 pg/ml versus 3.1 pg/ml (p = 0.0293) at 24 h, respectively. On the other hand, the median levels of IFN-g and IFN-a constitutively produced by trophoblasts of HIV-1-infected and control women over the 24-h period were similar. The median constitutive levels of IFN-a produced by the trophoblasts of HIV-1-infected compared with control women were 4.2 pg/ml versus 4.4 pg/ml at 12 h and 4.6 pg/ml versus 4.8 pg/ml at 24 h, respectively. Similarly, the median constitutive levels of IFN-g produced by the trophoblasts of HIV-1-infected and control women over a 24-h period were 17.8 pg/ml and 14.4 pg/ml at 12 h compared with 17.8 pg/ml and 11.5 pg/ml at 24 h, respectively.
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Transcription of IFN-b by placental trophoblasts
The 
Production of b-chemokines by placental trophoblasts
Constitutive levels of MIP-1a, MIP-1b, and RANTES in culture supernatants of 17 HIV-1-infected and 7 control subjects were determined by enzyme-linked immunosorbent assay (ELISA). The medians of the constitutive levels of MIP-1a, MIP-1b, and RANTES produced by trophoblasts of HIV-1-infected women were 1025 pg/ml, 1236 pg/ml, and 160 pg/ml, respectively. The medians of the constitutive levels of MIP-1a, MIP-1b and RANTES produced by trophoblasts of control women were 1628 pg/ml, 355 pg/ml, and 359 pg/ml, respectively. Trophoblasts of HIV-1-infected women constitutively produced more MIP-1b and less MIP-1a and RANTES compared with those of the control women ( Figure 3 ). However, there were no statistical differences in the constitutive production of these b-chemokines by trophoblasts of HIV-1-infected and control women. After 24 h in culture, trophoblasts of HIV-1-infected and control women produced comparable levels of b-chemokines (data not shown). There was no correlation between the amounts of b-chemokines produced by trophoblasts and their HIV-1 burden. first trimester trophoblasts producing 5-6 times more IFNs than third trimester trophoblasts 41, 42 . Among the IFNs produced locally by the placenta during pregnancy 43 , IFN-b is the predominant species and possesses more antiviral potential than IFN-a 40 . In the present study, trophoblasts isolated from term placentas of HIV-1-infected and control women produced equivalent levels of IFN-a. In contrast, trophoblasts from HIV-1-infected women produced significantly more IFN-b than trophoblasts of control women. The differential expression of IFN-b and not IFN-a by HIV-1-infected trophoblasts may be due, in part, to differences in transcriptional regulation, since the promoter of IFN-b, and not the promoter of IFN-a, contains an NF-kB binding site 44 . This difference, along with the induction of NF-kB by HIV-1 45 , suggests that HIV-1 is a potent inducer of IFN-b.
DISCUSSION
Alternatively, IFN-b transcription can be induced by TNF-a 46 , a cytokine previously shown to be present at elevated levels in trophoblasts of HIV-1-infected women 14 . Hence it is plausible that HIV-1 together with the HIV-1-induced TNF-a is capable of acting synergistically through the multipoietic transcription factor NF-kB to stimulate the production of IFN-b by HIV-1-infected trophoblasts. On the other hand TNF-a may directly or indirectly potentiate the antiviral activity of a type II IFN, IFN-g, through the induction of IFN-b 46 . Indeed, the major component of the antiviral activity of IFN-g may be due to its induction of IFN-a and IFN-b 47 . Within the placenta and throughout gestation, IFN-g is produced by Hofbauer cells and syncytiotrophoblasts 48, 49 . IFN-g may protect the host cells from infection with HIV-1 by inhibiting binding of the virus with the coreceptor CCR5 on the target cell 50 . As part of its role in immune activation, IFN-g induces 2¢,5¢-oligoadenylate (2-5A) synthetase activity to suppress HIV-1 replication in trophoblasts 51 . Nevertheless, we detected equivalent amounts of IFN-g produced by trophoblasts of HIV-1-infected and control women and found that there was no correlation between IFN-g production and the HIV burden of placental trophoblasts.
b-Chemokines can prevent cells from being infected with HIV-1 by blocking the interaction between the virus and the chemokine receptors on the cells 33, 34 . Although RANTES and MIP-1a are capable of binding with more than one chemokine receptor, MIP-1b can only bind with CCR5 52 . A previous study detected no RANTES and only low levels of MIP-1a and MIP-1b in cultures of early trophoblasts either infected or uninfected with HIV-1 30 . Not only were RANTES, MIP-1a, and MIP-1b detected in cultures of term trophoblasts from HIV-1-infected women in the present study, but higher levels of MIP-1b, and not MIP-1a or RANTES, were produced by trophoblasts of HIV-1-infected women compared to control women (1236 vs 355 pg/ml) (Figure 3) . The increase in MIP-1b production alone by term trophoblasts suggests that infection of the fetus with HIV-1 may be prevented by blocking of CCR5.
CONCLUSIONS
Despite the up-regulation in the transcription and production of the inflammatory cytokines IL-1b, IL-6, and TNF-a by trophoblasts of HIV-1-infected women, in this study only a low level of HIV-1 replication was detected in term trophoblasts 14 which may be, in part, owing to the combined antiviral activity of the three IFN species 47 . It has been reported that only minute amounts of these proteins are required to prevent HIV-1 infection of target cells 39 . Alternatively, reduction in virus burden in 23 of the 29 HIV-1-infected pregnant women may be due to ZDV anti-retroviral therapy ( Table 1 ). The exact mechanism by which trophoblast IFNs defend the fetus against infection with HIV-1 in the fetoplacental unit is unclear. Some workers have suggested that IFNs can directly suppress HIV-1 replication 39,40 through transcriptional regulation 44 and down-regulation of CD4 receptor expression on susceptible cells 50 . However, the present study was unable to demonstrate an inverse correlation between the level of HIV-1-gag transcripts and the production of interferons by placental trophoblasts. Although the production of b-chemokines by trophoblasts of HIV-1-infected and control women were similar, these chemokines may act synergistically to control the spread of HIV-1 from maternal to fetal cells at the local level. Further studies are therefore warranted to establish the role of IFNs and b-chemokines in preventing transmission of HIV-1 from mother to fetus.
